Regulated formation of eicosanoids

[1] ANGGARD E, 1965, J BIOL CHEM, V240, P3518

[2] BORGEAT P, 1976, J BIOL CHEM, V251, P7816

[3] Arachidonic acid as a bioactive molecule [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (11) : 1339 - 1345

[4] Chan G, 1999, CANCER RES, V59, P991

[5] Oxidation of NO mediated by water-soluble iron porphyrin [J]. ELECTROCHEMISTRY COMMUNICATIONS, 1999, 1 (07) : 274 - 277

[6] Chulada PC, 2000, CANCER RES, V60, P4705

[7] SUPPRESSION OF THROMBOXANE-A2 BUT NOT OF SYSTEMIC PROSTACYCLIN BY CONTROLLED-RELEASE ASPIRIN [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (16) : 1137 - 1141

[8] REQUIREMENT OF A 5-LIPOXYGENASE-ACTIVATING PROTEIN FOR LEUKOTRIENE SYNTHESIS [J]. NATURE, 1990, 343 (6255) : 282 - 284

[9] FEINMARK SJ, 1986, J BIOL CHEM, V261, P6466

[10] INDOMETHACIN AND ASPIRIN ABOLISH PROSTAGLANDIN RELEASE FROM SPLEEN [J]. NATURE-NEW BIOLOGY, 1971, 231 (25): : 237 - &

[1] ANGGARD E, 1965, J BIOL CHEM, V240, P3518

[2] BORGEAT P, 1976, J BIOL CHEM, V251, P7816

[3] Arachidonic acid as a bioactive molecule [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (11) : 1339 - 1345

[4] Chan G, 1999, CANCER RES, V59, P991

[5] Oxidation of NO mediated by water-soluble iron porphyrin [J]. ELECTROCHEMISTRY COMMUNICATIONS, 1999, 1 (07) : 274 - 277

[6] Chulada PC, 2000, CANCER RES, V60, P4705

[7] SUPPRESSION OF THROMBOXANE-A2 BUT NOT OF SYSTEMIC PROSTACYCLIN BY CONTROLLED-RELEASE ASPIRIN [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (16) : 1137 - 1141

[8] REQUIREMENT OF A 5-LIPOXYGENASE-ACTIVATING PROTEIN FOR LEUKOTRIENE SYNTHESIS [J]. NATURE, 1990, 343 (6255) : 282 - 284

[9] FEINMARK SJ, 1986, J BIOL CHEM, V261, P6466

[10] INDOMETHACIN AND ASPIRIN ABOLISH PROSTAGLANDIN RELEASE FROM SPLEEN [J]. NATURE-NEW BIOLOGY, 1971, 231 (25): : 237 - &